DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
  • Stocks
  • /
  • Pharmaceuticals & Biotech
Updated 1d ago
AVG logo

Avantor, Inc.XTRA:AVG Stock Report

Market Cap €8.7b
Updated 1d ago
Share Price
n/a
1Yn/a
7D-1.0%
1D-1.9%
Portfolio Value
​
View

Avantor, Inc.

XTRA:AVG Stock Report

Market Cap: €8.7b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Avantor (AVG) Stock Overview

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. More details

AVG fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Rewards

Trading at 19.5% below our estimate of its fair value

Earnings are forecast to grow 93.73% per year

Risk Analysis

Interest payments are not well covered by earnings

Volatile share price over the past 3 months compared to the German market


AVG Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW437,855 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
437,855 investors already sharing narratives
€
Current Price
€12.6761.3% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-578m8b2016201920222025202620282031Revenue US$7.5bEarnings US$979.3m
Advanced
View all narratives

Avantor, Inc. Competitors

Sartorius

Symbol: XTRA:SRT3
Market cap: €14.3b

SCHOTT Pharma KGaA

Symbol: XTRA:1SXP
Market cap: €3.5b

Gerresheimer

Symbol: XTRA:GXI
Market cap: €1.0b

Evotec

Symbol: XTRA:EVT
Market cap: €541.1m

Price History & Performance

Summary of share price highs, lows and changes for Avantor
Historical stock prices
Current Share PriceUS$12.67
52 Week HighUS$13.13
52 Week LowUS$8.20
Beta0.89
1 Month Change6.78%
3 Month Change52.98%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO49.82%

Recent News & Updates

Recent updates

Shareholder Returns

AVGDE Life SciencesDE Market
7D-1.0%-4.4%-2.1%
1Yn/a9.5%3.6%

Return vs Industry: Insufficient data to determine how AVG performed against the German Life Sciences industry.

Return vs Market: Insufficient data to determine how AVG performed against the German Market.

Price Volatility

Is AVG's price volatile compared to industry and market?
AVG volatility
AVG Average Weekly Movement11.1%
Life Sciences Industry Average Movement6.7%
Market Average Movement5.1%
10% most volatile stocks in DE Market12.6%
10% least volatile stocks in DE Market2.6%

Stable Share Price: AVG's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine AVG's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
190413,500Emmanuel Lignerwww.avantorsciences.com

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies.

Avantor, Inc. Fundamentals Summary

How do Avantor's earnings and revenue compare to its market cap?
AVG fundamental statistics
Market cap€8.67b
Earnings (TTM)-€497.77m
Revenue (TTM)€5.65b
1.5x
P/S Ratio
-17.4x
P/E Ratio

Is AVG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AVG income statement (TTM)
RevenueUS$6.56b
Cost of RevenueUS$4.47b
Gross ProfitUS$2.09b
Other ExpensesUS$2.67b
Earnings-US$578.00m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.85
Gross Margin31.83%
Net Profit Margin-8.81%
Debt/Equity Ratio65.2%

How did AVG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 14:57
End of Day Share Price 2026/09/10 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Avantor, Inc. is covered by 30 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert BambergerBaird
Catherine Ramsey SchulteBaird
Luke SergottBarclays

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide